Skip to main content
SpringerLink
Log in

Long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliation

  • Conference paper
Cancer Treatment An Update

Abstract

Before Bleomycin (BLM) was developed, there were almost no reports on the 5-year survivals of the patients with recurrent or advanced head and neck cancer who was treated with chemotherapy alone. After the appearance of BLM, however, there are some reports on the long-term surviving patients cured with BLM, but only in early or small recurrent diseases. Since combination chemotherapy based on cell kinetics and Cisplatin (CDDP) appeared, we have observed the long-term survivals even in recurrent or advanced cancer [1]. The purpose of this paper is to present the long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Inuyama Y, Horiuchi M et al (1982) Clinical effect of Cisplatin (NK-801) on head neck cancer. Jpn J Clin Oncol 12: 355–362

    Google Scholar 

  2. Inuyama Y, Fujii M et al (1986) Combination chemotherapy with Cisplatin and Peplomycin in squamous cell carcinoma of the head and neck. Auris Nasus Larynx 13: 191–198

    Article  PubMed  CAS  Google Scholar 

  3. Inuyama Y, Fukuda S et al (1990) Prolongation of life and improvement of quality of life with use of chemotherapy for advanced or recurrent head and neck cancer. In: Sacristan T (ed) Otorhinolaryngology, Head & Neck Surgery. Kugler & Ghedini Publication, Amsterdam, p. 2651

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Hokkaido University School of Medecine, Kita-15, Nishi-7, Kita-Ku, Sapporo, 060, Japan

    Y. Inuyama

Authors
  1. Y. Inuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Saint-Louis, 1, avenue Vellefaux, 75475, Paris Cedex 10, France

    P. Banzet

  2. The Mount Sinai Medical Center, 1 G. Levy Place, New York, NY, 10029-6574, USA

    J. F. Holland

  3. Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    D. Khayat

  4. Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    M. Weil

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag France

About this paper

Cite this paper

Inuyama, Y. (1994). Long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliation. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_54

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0765-2_54

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0767-6

  • Online ISBN: 978-2-8178-0765-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation